STE Stock Falls -11% In A 7-day Losing Spree On Insider Sale And Margin Worries
Steris (STE) – a provider of infection prevention and sterilization products – hit a 7-day losing streak, with cumulative losses over this period amounting to -11%. The company’s market cap has crashed by about $2.6 Bil over the last 7 days and currently stands at $22 Bil.
The stock has YTD (year-to-date) return of 9.9% compared to -0.7% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Slide?
[1] Insider Stock Sale and Underlying Margin Concerns
- With Strong Cash Flow, Blackstone Stock Poised to Rise?
- Pay Less, Gain More: GIB Tops Accenture Stock
- Stronger Bet Than CME Stock: MCO, SPGI Deliver More
- Why PTC Could Outperform Intuit Stock
- Better Value & Growth: GD, TDG Lead Lockheed Martin Stock
- Better Value & Growth: LTM Leads Southwest Airlines Stock
- A director sold 3,098 shares on March 5th
- Gross margin contracted 72 basis points in the recent quarter
- Impact: Sustained Selling Pressure, Negative Investor Sentiment
[2] Technical Breakdown and Broader Market Headwinds
- MACD indicator signaled cautious sentiment on March 2nd
- Broader market decline due to geopolitical tensions
- Impact: Price drop below 50-day moving average, Increased risk-off sentiment among investors
Opportunity or Trap?
Below is our take on valuation.
There is a near-equal mix of good and bad in STE stock given its overall Moderate operating performance and financial condition. This is aligned with the stock’s Moderate valuation because of which we think it is Fairly Priced (For details, see Buy or Sell STE).
But here is the real interesting point.
You are reading about this -11% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has a risk model designed to reduce exposure to losers.
Returns vs S&P 500
The following table summarizes the return for STE stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | STE | S&P 500 |
|---|---|---|
| 1D | -1.2% | 0.8% |
| 7D (Current Streak) | -10.6% | -1.6% |
| 1M (21D) | -6.4% | -0.0% |
| 3M (63D) | -12.5% | -0.9% |
| YTD 2026 | -9.9% | -0.7% |
| 2025 | 24.6% | 16.4% |
| 2024 | -5.6% | 23.3% |
| 2023 | 20.2% | 24.2% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 14 S&P constituents with 3 days or more of consecutive gains and 99 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 6 | 53 |
| 4D | 3 | 7 |
| 5D | 2 | 16 |
| 6D | 3 | 16 |
| 7D or more | 0 | 7 |
| Total >=3 D | 14 | 99 |
Key Financials for Steris (STE)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $5.1 Bil | $5.5 Bil |
| Operating Income | $862.2 Mil | $960.8 Mil |
| Net Income | $378.2 Mil | $614.6 Mil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ2 | 2026 FQ3 |
|---|---|---|
| Revenues | $1.5 Bil | $1.5 Bil |
| Operating Income | $268.0 Mil | $273.7 Mil |
| Net Income | $191.9 Mil | $192.8 Mil |
The losing streak STE stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.